packageVismodegib

vismodegib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vismodegib is an anticancer medicine used to treat basal-cell carcinoma, a type of skin cancer. It is authorised in the European Union and carries a boxed warning because it can harm reproduction and fetal development.

Summary written by glm-5.3-flash from Wikidata Q2070286 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vismodegib
ATC codes:L01XJ01, L01XX43
DrugBank:DB08828
PubChem CID:24776445
ChEBI:66903
Wikidata:Q2070286
formula:C19H14Cl2N2O3S
molar mass:421.292 g/mol (PubChem CID 24776445)
logP:3.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown